Clinical Trial Update: Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients [Phase 1, Phase 2]

View source ↗

Summary

An ongoing phase 1/2 pediatric trial examines safety and potential efficacy of a four-drug combination (cyclophosphamide, sorafenib, bevacizumab, and atezolizum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrolamellar Hepatocellular Carcinoma
• Hepatocellular Carcinoma
• Solid Tumors

Drugs mentioned

• Avastin (bevacizumab)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Nexavar (Sorafenib)
• Tecentriq (atezolizumab)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Refractory Solid Tumor, Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: RECRUITING